Showing results (441-450 of 455) with videos related to
Sort By:
Pageof 46
Lupus|March 14, 2000
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusM Galeazzi, G D Sebastiani, A Tincani, et al.Lupus|August 2, 2003
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusG D Sebastiani, M Galeazzi, A Tincani, et al.The Journal of Pediatrics|May 5, 2005
Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter studyB Bader-Meunier, J B Armengaud, E Haddad, et al.Annals of the Rheumatic Diseases|April 25, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpointsG K Bertsias, J P A Ioannidis, J Boletis, et al.Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1997
[Mass screening programs for breast cancer in France. Comparative evaluation]A Lacour, N Mamelle, F Arnold, et al.Annals of the Rheumatic Diseases|April 5, 2008
EULAR points to consider for conducting clinical trials in systemic lupus erythematosusC Gordon, G Bertsias, J P A Ioannidis, et al.Lupus|March 31, 2017
Cessation of oral anticoagulants in antiphospholipid syndromeC Comarmond, P Jego, C Veyssier-Belot, et al.Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2015
Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosusM Jallouli, L Galicier, N Zahr, et al.Pageof 46